AU Patent

AU2025203232A1 — Methods of making bempedoic acid and compositions of the same

Assigned to Esperion Therapeutics Inc · Expires 2025-05-29 · 1y expired

What this patent protects

METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME ABSTRACT The invention provides methods of preparing 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8 hydroxy-2,2,14,14-tetrameth…

USPTO Abstract

METHODS OF MAKING BEMPEDOIC ACID AND COMPOSITIONS OF THE SAME ABSTRACT The invention provides methods of preparing 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid and methods of making a pharmaceutical material comprising a purified amount of 8 hydroxy-2,2,14,14-tetramethylpentadecanedioic acid. Also provided are compositions and pharmaceutical materials including a purified amount of 8-hydroxy-2,2,14,14 tetramethylpentadecanedioic acid as well as methods of treating various diseases and conditions using the compositions and pharmaceutical materials.

Drugs covered by this patent

Patent Metadata

Patent number
AU2025203232A1
Jurisdiction
AU
Classification
—
Expires
2025-05-29
Drug substance claim
No
Drug product claim
No
Assignee
Esperion Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.